Speculation surrounding a potential merger between GlaxoSmithKline and AstraZeneca has gained traction as GSK’s leadership undergoes a transition. Analysts recently suggested that the appointment of Luke Miels as GSK’s new
All posts tagged in Pascal Soriot
2Articles
AstraZenecas chief executive has described the pharmaceutical giant as a very American company following rising speculation about a potential shift of its main stock market listing from London to New
